Table 2.
Samples (n = 119) |
||
CAP | VAP | |
Type of suspected pneumonia | 27 (22.7) | 92 (77.3) |
Confirmed diagnostic of pneumonia (% among suspected / % among total) |
6 (22.2 / 5.0) |
48 (52.2 / 40.3) |
Type of samples: ETA BAL |
15 12 |
59 33 |
Antibiotics 48h prior to samples (n = 55) | 15 (55.6) | 40 (43.5) |
Bacterial copathogens: Staphylococcus aureus Pseudomonas aeruginosa Haemophilus influenzae Escherichia coli Klebsiella pneumoniae Enterobacter cloacae Klebsiella aerogenes Proteus spp. Serratia marcescens Streptococcus agalactiae Moraxella catarrhalis Mycoplasma pneumoniae Morganella morganii Hafnia alvei Providencia stuartii |
FAPP / CC 0 / 0 0 / 0 4 / 0 0 / 0 1 / 1 0 / 0 0 / 0 0 / 0 0 / 0 0 / 0 1 / 0 1 / NA NA / 0 NA / 0 NA / 0 |
FAPP / CC 17 / 12 11 / 11 6 / 3 9 / 5 6 / 6 5 / 5 4 / 2 4 / 3 3 / 3 3 / 1 1 / 1 0 / NA NA / 2 NA / 1a NA / 1a |
Resistance detection: MRSA 3GC-R Gram-negative bacilli |
FAPP / AST 0 / 0 0 / 0 |
FAPP / AST 6 / 0 5 / 6b |
Type of pneumonia | CAP | VAP |
Contribution of FAPP at first intensivist decisionc No modification of empirical antibiotics Speeded-up adequate antibiotic Antibiotic spared Inappropriate antibiotic treatment Inappropriate stopped antibiotic |
0 2 (20.0) 8 (80.0) 0 0 |
3 (7.5) 9 (22.5) 20 (50.0) 7 (17.5) 1 (2.5) |
Contribution of FAPP based on MEC analysise No modification of empirical antibiotics Speeded-up adequate antibiotic Antibiotic spared Inappropriate antibiotic treatment Inappropriate stopped antibiotic |
1 (3.7) 4 (14.8) 22 (81.5) 0 0 |
11 (12.0) 13 (14.1) 56 (60.9) 10 (10.9) 2 (2.2) |
Data are presented as: n (%).
ETA = endotracheal aspirate; BAL = bronchoalveolar lavage; CAP = community-acquired pneumonia (defined as infections occurring during the first 48h of ICU admission); VAP = ventilator-associated pneumonia; FAPP = FilmArray® Pneumonia Panel; CC = conventional culture; AST = antimicrobial susceptibility testing; MRSA = methicillin-resistant S. aureus; 3GC-R = third generation cephalosporins resistance; NA = not applicable (species not detected either by the FAPP or by the CC); MEC = multidisciplinary expert committee.
a The isolation of H. alvei and P. stuartii in CC had no impact on antibiotic therapy as they were covered by the antibiotics administered following the detection of other pathogens detected by FAPP.
b Among 3GC-resistant Gram-negative bacilli, 3 CTX-M were detected by both FAPP and CC, 2 CTX-M were detected only by FAPP, 2 ESBL not belonging to CTX-M as well as one 3GC-resistant P. aeruginosa were detected only by CC.
c A contribution of FAPP at first intensivist decision was noted in 50 samples (42.0%).
d Decrease unnecessary antibiotic use (interruption or de-escalation).
e Theoretical contribution of FAPP after MEC analysis of the 119 samples (100.0%).